Notably, AH680, a selective antagonist of EP1/EP2 receptors, exerted an inhibitory effect on COX-2-dependent VEGF expression in NSCLC cells (p < 0.05). The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.